vs
Donnelley Financial Solutions, Inc.（DFIN）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Ultragenyx Pharmaceutical Inc.的季度营收约是Donnelley Financial Solutions, Inc.的1.2倍（$207.3M vs $172.5M），Donnelley Financial Solutions, Inc.净利率更高（3.6% vs -62.0%，领先65.6%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 10.4%），Donnelley Financial Solutions, Inc.自由现金流更多（$47.9M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs -7.9%）
唐nelley金融解决方案（DFIN）是一家总部位于美国伊利诺伊州芝加哥市的金融合规企业，面向资本市场与投资市场的各类企业，提供符合美国监管要求的软件即服务产品、软件赋能服务、印刷业务及合规相关服务，助力客户满足合规要求。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
DFIN vs RARE — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $172.5M | $207.3M |
| 净利润 | $6.2M | $-128.6M |
| 毛利率 | — | — |
| 营业利润率 | 8.3% | -54.7% |
| 净利率 | 3.6% | -62.0% |
| 营收同比 | 10.4% | 25.9% |
| 净利润同比 | -1.6% | 3.5% |
| 每股收益（稀释后） | $0.31 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $172.5M | $207.3M | ||
| Q3 25 | $175.3M | $159.9M | ||
| Q2 25 | $218.1M | $166.5M | ||
| Q1 25 | $201.1M | $139.3M | ||
| Q4 24 | $156.3M | $164.6M | ||
| Q3 24 | $179.5M | $139.5M | ||
| Q2 24 | $242.7M | $147.0M | ||
| Q1 24 | $203.4M | $108.8M |
| Q4 25 | $6.2M | $-128.6M | ||
| Q3 25 | $-40.9M | $-180.4M | ||
| Q2 25 | $36.1M | $-115.0M | ||
| Q1 25 | $31.0M | $-151.1M | ||
| Q4 24 | $6.3M | $-133.2M | ||
| Q3 24 | $8.7M | $-133.5M | ||
| Q2 24 | $44.1M | $-131.6M | ||
| Q1 24 | $33.3M | $-170.7M |
| Q4 25 | 8.3% | -54.7% | ||
| Q3 25 | 16.1% | -106.9% | ||
| Q2 25 | 24.2% | -64.8% | ||
| Q1 25 | 22.8% | -102.6% | ||
| Q4 24 | 6.0% | -74.3% | ||
| Q3 24 | 10.1% | -94.6% | ||
| Q2 24 | 26.6% | -79.1% | ||
| Q1 24 | 21.9% | -151.9% |
| Q4 25 | 3.6% | -62.0% | ||
| Q3 25 | -23.3% | -112.8% | ||
| Q2 25 | 16.6% | -69.0% | ||
| Q1 25 | 15.4% | -108.5% | ||
| Q4 24 | 4.0% | -80.9% | ||
| Q3 24 | 4.8% | -95.7% | ||
| Q2 24 | 18.2% | -89.5% | ||
| Q1 24 | 16.4% | -156.8% |
| Q4 25 | $0.31 | $-1.28 | ||
| Q3 25 | $-1.49 | $-1.81 | ||
| Q2 25 | $1.28 | $-1.17 | ||
| Q1 25 | $1.05 | $-1.57 | ||
| Q4 24 | $0.21 | $-1.34 | ||
| Q3 24 | $0.29 | $-1.40 | ||
| Q2 24 | $1.47 | $-1.52 | ||
| Q1 24 | $1.09 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $24.5M | $421.0M |
| 总债务越低越好 | $171.3M | — |
| 股东权益账面价值 | $379.2M | $-80.0M |
| 总资产 | $800.4M | $1.5B |
| 负债/权益比越低杠杆越低 | 0.45× | — |
8季度趋势，按日历期对齐
| Q4 25 | $24.5M | $421.0M | ||
| Q3 25 | $22.7M | $202.5M | ||
| Q2 25 | $33.8M | $176.3M | ||
| Q1 25 | $16.2M | $127.1M | ||
| Q4 24 | $57.3M | $174.0M | ||
| Q3 24 | $33.6M | $150.6M | ||
| Q2 24 | $35.0M | $480.7M | ||
| Q1 24 | $43.7M | $112.3M |
| Q4 25 | $171.3M | — | ||
| Q3 25 | $154.7M | — | ||
| Q2 25 | $190.1M | — | ||
| Q1 25 | $189.5M | — | ||
| Q4 24 | $124.7M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $379.2M | $-80.0M | ||
| Q3 25 | $423.1M | $9.2M | ||
| Q2 25 | $432.1M | $151.3M | ||
| Q1 25 | $419.9M | $144.2M | ||
| Q4 24 | $436.1M | $255.0M | ||
| Q3 24 | $444.5M | $346.8M | ||
| Q2 24 | $441.5M | $432.4M | ||
| Q1 24 | $408.9M | $140.3M |
| Q4 25 | $800.4M | $1.5B | ||
| Q3 25 | $816.3M | $1.2B | ||
| Q2 25 | $874.7M | $1.3B | ||
| Q1 25 | $852.8M | $1.3B | ||
| Q4 24 | $841.6M | $1.5B | ||
| Q3 24 | $843.6M | $1.5B | ||
| Q2 24 | $882.9M | $1.6B | ||
| Q1 24 | $867.8M | $1.3B |
| Q4 25 | 0.45× | — | ||
| Q3 25 | 0.37× | — | ||
| Q2 25 | 0.44× | — | ||
| Q1 25 | 0.45× | — | ||
| Q4 24 | 0.29× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $59.8M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $47.9M | $-100.8M |
| 自由现金流率自由现金流/营收 | 27.8% | -48.6% |
| 资本支出强度资本支出/营收 | 6.9% | 0.5% |
| 现金转化率经营现金流/净利润 | 9.65× | — |
| 过去12个月自由现金流最近4个季度 | $107.8M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $59.8M | $-99.8M | ||
| Q3 25 | $74.4M | $-91.4M | ||
| Q2 25 | $68.4M | $-108.3M | ||
| Q1 25 | $-37.7M | $-166.5M | ||
| Q4 24 | $56.4M | $-79.3M | ||
| Q3 24 | $86.4M | $-67.0M | ||
| Q2 24 | $56.2M | $-77.0M | ||
| Q1 24 | $-27.9M | $-190.7M |
| Q4 25 | $47.9M | $-100.8M | ||
| Q3 25 | $59.2M | $-92.7M | ||
| Q2 25 | $51.7M | $-110.7M | ||
| Q1 25 | $-51.0M | $-167.8M | ||
| Q4 24 | $41.3M | $-79.5M | ||
| Q3 24 | $67.3M | $-68.6M | ||
| Q2 24 | $36.8M | $-79.0M | ||
| Q1 24 | $-40.2M | $-193.9M |
| Q4 25 | 27.8% | -48.6% | ||
| Q3 25 | 33.8% | -58.0% | ||
| Q2 25 | 23.7% | -66.5% | ||
| Q1 25 | -25.4% | -120.5% | ||
| Q4 24 | 26.4% | -48.3% | ||
| Q3 24 | 37.5% | -49.2% | ||
| Q2 24 | 15.2% | -53.7% | ||
| Q1 24 | -19.8% | -178.2% |
| Q4 25 | 6.9% | 0.5% | ||
| Q3 25 | 8.7% | 0.8% | ||
| Q2 25 | 7.7% | 1.5% | ||
| Q1 25 | 6.6% | 1.0% | ||
| Q4 24 | 9.7% | 0.1% | ||
| Q3 24 | 10.6% | 1.2% | ||
| Q2 24 | 8.0% | 1.4% | ||
| Q1 24 | 6.0% | 3.0% |
| Q4 25 | 9.65× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 1.89× | — | ||
| Q1 25 | -1.22× | — | ||
| Q4 24 | 8.95× | — | ||
| Q3 24 | 9.93× | — | ||
| Q2 24 | 1.27× | — | ||
| Q1 24 | -0.84× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DFIN
| Technology Service | $68.0M | 39% |
| Capital Markets Compliance And Communications Management | $61.6M | 36% |
| Investment Companies Software Solutions | $30.9M | 18% |
| Print And Distribution Service | $13.6M | 8% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
